Abstract
Background
Binding of thyroglobulin (Tg) to heparin is involved in Tg transcytosis via megalin. Rat Tg (rTg) binds to heparin through an exposed carboxyl terminal region (RELPSRRLKRPLPVK, Arg2489-Lys2503) rich in positively charged residues. This region is not entirely conserved in human Tg (hTg) (Arg2489-Glu2503, REPPARALKRSLWVE), resulting in lower affinity binding. Here, we developed a score to predict to what extent secondary structure modifications affect the heparin-binding ability of rTg.
Methods
We designed eight synthetic peptides, including one with the Arg2489-Lys2503 sequence of rTg (rTgP), one with the corresponding sequence of hTg (hTgP), and six “mutant” peptides, each carrying a point mutation obtained by replacing one amino acid residue of rTgP with the corresponding residue of hTgP. Heparin binding was assessed in solid-phase assays. The Bmax and the constants of dissociation (Kd) were calculated.
Results
Using a no-fee online service, we obtained predictions of peptide secondary structures and developed a scoring system to estimate to what extent mutations are expected to modify rTg secondary structure. The score was designated as Probability of Secondary Structure Change (PSSC) and it significantly correlated with the BMax (R = 0.942, P < 0.001) and the Kds (R = − 0.744, P < 0.01) of heparin binding of hTgP and of the “mutant” peptides.
Conclusions
The PSSC score allows predicting to what extent point mutations are likely to affect the heparin-binding ability of short sequences of proteins: in this case rTg, regardless of whether mutations affect charge of the sequence. The secondary structure of Tg is likely to play a role in heparin binding.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cardin AD, Weintraub HJR (1989) Molecular modeling of protein–glycosaminoglycan interactions. Atherosclerosis 9:21–32
Marinò M, Zheng G, McCluskey RT (1999) Megalin (gp330) is an endocytic receptor for thyroglobulin on cultured fisher rat thyroid cells. J Biol Chem 274:12898–12904
Marinò M, Zheng G, Chiovato L, Pinchera A, Brown D, Andrews D, McCluskey RT (2000) Role of megalin (gp330) in transcytosis of thyroglobulin by thyroid cells: a novel function in the control of thyroid hormone release. J Biol Chem 275:7125–7138
Lisi S, Pinchera A, McCluskey RT, Willnow TE, Refetoff S, Marcocci C, Vitti P, Menconi F, Grasso L, Luchetti F, Collins AB, Marinò M (2003) Preferential megalin-mediated transcytosis of low-hormonogenic thyroglobulin: a control mechanism for thyroid hormone release. Proc Natl Acad Sci USA 100:14858–14863
Botta R, Lisi S, Rotondo Dottore G, Vitti P, Marinò M (2017) Binding of thyroglobulin (Tg) to the low-density lipoprotein receptor-associated protein (RAP) during the biosynthetic pathway prevents premature Tg interactions with sortilin. J Endocrinol Invest 40:991–997
Lisi S, Botta R, Rotondo Dottore G, Leo M, Latrofa F, Vitti P, Marinò M (2016) Intracellular retention of thyroglobulin in the absence of the low-density lipoprotein receptor-associated protein (RAP) is likely due to premature binding to megalin in the biosynthetic pathway. J Endocrinol Invest 39:1039–1044
Marinò M, Andrews D, McCluskey RT (2000) Binding of thyroglobulin to heparan sulfate proteoglycans. Thyroid 10:551–559
Marinò M, Friedlander JA, McCluskey RT, Andrews D (1999) Identification of a heparin-binding region of rat thyroglobulin involved in megalin binding. J Biol Chem 274:30377–30386
Caturegli P, Vidalain PO, Vali M, Aguilera-Galaviz LA, Rose NR (1997) Cloning and characterization of murine thyroglobulin cDNA. Clin Immunol Immunopathol 85:221–226
Malthiery Y, Lissitzky S (1987) Primary structure of human thyroglobulin deduced from the sequence of its 8448-base complementary DNA. Eur J Biocehm 165:491–498
Lisi S, Pinchera A, McCluskey RT, Chiovato L, Marinò M (2002) Binding of heparin to human thyroglobulin (Tg) involves multiple binding sites including a region corresponding to a binding site of rat Tg. Eur J Endocrinol 146:591–602
Nettore IC, Cacace V, De Fusco C, Colao A, Macchia PE (2013) The molecular causes of thyroid dysgenesis: a systematic review. J Endocrinol Invest 36:654–664
Lisi S, Segnani C, Mattii L, Botta R, Marcocci C, Dolfi A, McCluskey RT, Pinchera A, Bernardini N, Marinò M (2005) Thyroid dysfunction in megalin deficient mice. Mol Cell Endocrinol 236:43–47
Alexandrov NN, Nussinov R, Zimmer RM (1996) Fast protein fold recognition via sequence to structure alignment and contact capacity potentials. Pac Symp Biocomput 53–72
Coscia F, Taler-Verčič A, Chang VT, Sinn L, O'Reilly FJ, Izoré T, Renko M, Berger I, Rappsilber J, Turk D, Löwe J (2020) The structure of human thyroglobulin. Nature 578:627–630
Acknowledgements
The study was funded by the University of Pisa (Fondi di Ateneo, to MM).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
The article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
Not applicable. No human subjects are involved.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Lisi, S., Marinò, M. Prediction of heparin binding of mutated short sequences of rat thyroglobulin. J Endocrinol Invest 44, 1237–1241 (2021). https://doi.org/10.1007/s40618-020-01411-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-020-01411-5